Pediatric Blastomycosis Clinical Presentation
- Author: Russell W Steele, MD; Chief Editor: Russell W Steele, MD more...
History
The clinical spectrum of blastomycosis widely varies, including asymptomatic infection (in nearly one half of patients infected), acute or chronic pneumonia, and extrapulmonary disease.
Most cases of blastomycosis are sporadic. Nearly one half of patients infected may be asymptomatic. In one study involving 46 children and 2 adults, symptoms began 21-106 days (median 45 d) after exposure to the pathogen in a beaver pond.[4] Patients may complain of an influenzalike illness with the following nonspecific constitutional symptoms:
- Fever
- Chills
- Night sweats
- Weight loss
- Malaise
- Myalgia
Acute pulmonary infection is the most frequent presentation of blastomycosis in children. Symptoms include the following:
- Productive cough
- Dyspnea
- Wheezing
- Chest pain
- Hemoptysis (rarely)
Symptoms of chronic pneumonia may last for 2-6 months and include weight loss, night sweats, fever, cough, and chest pain. Most adult patients diagnosed with blastomycosis have an indolent onset of chronic pneumonia.
Physical
Signs of acute or chronic pneumonia may be noted. Life-threatening progressive lung disease and disseminated infection can occur in 10% of reported cases.
Disseminated blastomycosis usually begins with pulmonary infection followed by cutaneous, osseous, genitourinary, or CNS involvement.
Less commonly, primary cutaneous blastomycosis may follow after traumatic inoculation of the fungus into the skin (see the image below).
Cutaneous blastomycosis. Extrapulmonary disease in blastomycosis includes the following:
- Skin, most commonly (25%)
- Bone (25%)
- Prostatitis or epididymitis (17%): This is a common manifestation in adults and is not reported in prepubescent children.
- Neurologic involvement: This occurs in 3-5% of extrapulmonary infections and is manifested as intracranial or epidural abscesses and, rarely, meningitis.
Skin lesions are the most common manifestation of extrapulmonary disease. Cutaneous lesions favor exposed areas and enlarge over many weeks, from pimples that are minimally tender to well-circumscribed verrucous or ulcerative lesions, often with little inflammation. Verrucous lesions demonstrate raised irregular borders with crusting and purulent drainage, whereas ulcerative lesions are characterized by sharp and heaped-up borders with centrally located granulation tissue and exudate.
Osteolytic lesions may occur in nearly any bone and present as a cold abscess or draining sinus.
Extension to a contiguous joint may result in indolent swelling, pain, and restriction of movement. The vertebra, skull, ribs, and long bones are most commonly affected.
Intrauterine or congenital infections are unusual.
Other unusual metastatic sites of infection include larynx, reticuloendothelial system (liver, spleen, lymph nodes, bone marrow), oropharynx, nose, and thyroid.
Causes
B dermatitidis is a thermal dimorphic fungus that occurs in mycelial form in nature and as yeast in infected tissue.
- The fungus grows on Sabouraud agar at room temperature (250°C) as a white fluffy mold. Alternatively, at body temperature (37°C) and on blood agar, the fungus forms a brown wrinkled colony.
- The mycelial form of B dermatitidis has been isolated from soil, although its ecologic niche is not characterized as well as other endemic fungi.
- Inhalation of the microconidia from the mold form of B dermatitidis into the lungs leads to infection.
- In infected tissue specimens, B dermatitidis appears as a characteristic thick-walled yeast cell (8- to 15-mcg diameter) with broad-based daughter cells.
Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med. May 15 1992;116(10):847-53. [Medline].
Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med. Oct 21 1993;329(17):1231-6. [Medline].
Schutze GE, Hickerson SL, Fortin EM, et al. Blastomycosis in children. Clin Infect Dis. Mar 1996;22(3):496-502. [Medline].
Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med. Feb 27 1986;314(9):529-34. [Medline].
[Guideline] Chapman SW, Bradsher RW JR, Campbell GD Jr, et al. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis. Apr 2000;30(4):679-83. [Medline].
Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med. Nov 1992;93(5):489-97. [Medline].
Dismukes WE, Cloud G, Bowles C. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Ann Intern Med. Dec 1985;103(6 ( Pt 1)):861-72. [Medline].
Pappas PG, Bradsher RW, Chapman SW, et al. Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. Feb 1995;20(2):267-71. [Medline].
Ta M, Flowers SA, Rogers PD. The role of voriconazole in the treatment of central nervous system blastomycosis. Ann Pharmacother. Oct 2009;43(10):1696-700. [Medline].
Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect. Sep 1997;12(3):219-28. [Medline].
Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J. Apr 2006;25(4):377-9. [Medline].
Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore). Sep 1993;72(5):311-25. [Medline].
Sarosi GA, Hammerman KJ, Tosh FE, Kronenberg RS. Clinical features of acute pulmonary blastomycosis. N Engl J Med. Mar 7 1974;290(10):540-3. [Medline].
Shetty AK, Quinonez JM, Steele RW. Fever, hemoptysis and pneumonia in a twelve-year-old girl. Pediatr Infect Dis J. Sep 1998;17(9):849; 852-3. [Medline].
Steele RW, Abernathy RS. Systemic blastomycosis in children. Pediatr Infect Dis. Jul-Aug 1983;2(4):304-7. [Medline].
Sugar AM, Picard M. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections. J Infect Dis. Feb 1991;163(2):371-5. [Medline].

